RenovoRx, Inc.RNXTNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+13.7%
5Y CAGR+21.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+13.7%/yr
Annual compound
5Y CAGR
+21.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$6.33M+5.0%
2024$6.03M+6.3%
2023$5.67M+31.8%
2022$4.30M+41.5%
2021$3.04M+27.4%
2020$2.39M-20.4%
2019$3.00M-